Generation of mesenchymal cell lines derived from aged donors

Loading...
Thumbnail Image

Identifiers

Publication date

Authors

Advisors

Other responsabilities

Journal Title

Bibliographic citation

Piñeiro-Ramil M, Sanjurjo-Rodríguez C, Rodríguez-Fernández S, Castro-Viñuelas R, Hermida-Gómez T, Blanco-García FJ, Fuentes-Boquete I, Díaz-Prado S. Generation of mesenchymal cell lines derived from aged donors. Int J Mol Sci. 2021 Oct 1;22(19):10667.

Type of academic work

Academic degree

Abstract

[Abstract] Background: Mesenchymal stromal cells (MSCs) have the capacity for self-renewal and multi-differentiation, and for this reason they are considered a potential cellular source in regenerative medicine of cartilage and bone. However, research on this field is impaired by the predisposition of primary MSCs to senescence during culture expansion. Therefore, the aim of this study was to generate and characterize immortalized MSC (iMSC) lines from aged donors. Methods: Primary MSCs were immortalized by transduction of simian virus 40 large T antigen (SV40LT) and human telomerase reverse transcriptase (hTERT). Proliferation, senescence, phenotype and multi-differentiation potential of the resulting iMSC lines were analyzed. Results: MSCs proliferate faster than primary MSCs, overcome senescence and are phenotypically similar to primary MSCs. Nevertheless, their multi-differentiation potential is unbalanced towards the osteogenic lineage. There are no clear differences between osteoarthritis (OA) and non-OA iMSCs in terms of proliferation, senescence, phenotype or differentiation potential. Conclusions: Primary MSCs obtained from elderly patients can be immortalized by transduction of SV40LT and hTERT. The high osteogenic potential of iMSCs converts them into an excellent cellular source to take part in in vitro models to study bone tissue engineering.

Description

Rights

Creative Commons Attribution 4.0 International Licence (CC-BY 4.0)
Creative Commons Attribution 4.0 International Licence (CC-BY 4.0)

Except where otherwise noted, this item's license is described as Creative Commons Attribution 4.0 International Licence (CC-BY 4.0)